Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | NPY2R | P49146 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4861748 | 0.99 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPTMEN1TP53 | |
| SCHEMBL8062335 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPTMEN1TP53 | |
| SCHEMBL1692156 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPTMEN1TP53 | |
| SCHEMBL8513482 | 0.92 | ALDH1A1 (0.49) | ALDH1A1TSHRMAPTMEN1TP53 | |
| Potassium SCHEMBL10603820 | 0.88 | TRPA1 (0.42) | ALDH1A1TSHRTP53KDM4EHTT | |
| Potassium SCHEMBL41206 | 0.86 | TSHR (0.51) | ALDH1A1TSHRMAPTMEN1TP53 | |
| SCHEMBL8646590 | 0.86 | TRPA1 (0.42) | ALDH1A1TSHRTP53KDM4EHTT | |
| SCHEMBL899854 | 0.85 | TSHR (0.53) | ALDH1A1TSHRMAPTMEN1TP53 | |
| Potassium SCHEMBL5865052 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TSHRTP53KDM4ETDP1 | |
| SCHEMBL16414281 | 0.84 | TSHR (0.51) | ALDH1A1TSHRMAPTMEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630390-A1 | CHEMICAL INHIBITORS FOR HIGH TEMPERATURE AND REACTIVE GROUND | Dyno Nobel Asia Pacific Pty Limited (AU) | 2025-10-15 | — | — | EP | claimed |
| CN-118811856-B | Preparation method and application of nano zinc sulfide with adjustable crystal structure | 湖南工商大学 | 2025-01-21 | — | — | CN | claimed |
| WO-2024119239-A1 | CHEMICAL INHIBITORS FOR HIGH TEMPERATURE AND REACTIVE GROUND | Dyno Nobel Asia Pacific Pty Limited (AU) | 2024-06-13 | — | — | WO | claimed |
| CN-117646113-A | Combined device and method for floatation and smelting lead and zinc in refractory complex ore | 柳州华锡有色设计研究院有限责任公司 | 2024-03-05 | — | — | CN | claimed |
| CN-111957293-B | Low-heavy metal high-adsorption silicon dioxide and preparation method thereof | 确成硅化学股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| EP-3404748-B1 | ELECTROCHEMICAL CELLS COMPRISING ADDITIVES | SION POWER CORP (US) | 2022-07-27 | — | — | EP | claimed |
| US-10944094-B2 | Passivating agents for electrochemical cells | SION POWER CORPORATION (US) | 2021-03-09 | — | — | US | claimed |
| CN-112403684-A | Synthesis method and application of xanthic acid-quaternary ammonium salt ionic liquid | 河南资环检测科技有限公司 | 2021-02-26 | — | — | CN | claimed |
| EP-3404749-B1 | ELECTROCHEMICAL CELLS COMPRISING ADDITIVES | SION POWER CORP (US) | 2021-02-17 | — | — | EP | claimed |
| CN-111957293-A | Low-heavy metal high-adsorption silicon dioxide and preparation method thereof | 确成硅化学股份有限公司 | 2020-11-20 | — | — | CN | claimed |
| CN-110945688-A | Passivating agent for electrochemical cells | 赛昂能源有限公司 | 2020-03-31 | — | — | CN | claimed |
| EP-3404748-A1 | ELECTROCHEMICAL CELLS COMPRISING ADDITIVES | BASF SE (DE) | 2018-11-21 | — | — | EP | claimed |
| EP-3404749-A1 | ELECTROCHEMICAL CELLS COMPRISING ADDITIVES | BASF SE (DE) | 2018-11-21 | — | — | EP | claimed |
| US-9889452-B2 | Methods for facilitating mineral extraction | CHEMTREAT, INC. (US) | 2018-02-13 | — | — | US | claimed |
| US-20150174588-A1 | METHODS FOR FACILITATING MINERAL EXTRACTION | CHEMTREAT, INC. (US) | 2015-06-25 | — | — | US | claimed |
| US-20260145977-A1 | SYSTEM AND METHOD OF USING NANOBUBBLES IN A DEWATERING PROCESS FOR A LIQUID-SOLID STREAM | Moleaer, Inc. (US) | 2026-05-28 | — | — | US | disclosed |
| US-12614711-B2 | Passivating agents for electrochemical cells | SION POWER CORPORATION (US) | 2026-04-28 | — | — | US | disclosed |
| US-4442294-A | Process for the preparation of halo-2-mercaptobenzoxazoles | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-04-10 | — | — | US | disclosed |
| US-4431813-A | HEATING 2-HALOANILINES AND AN ALKALI OR ALKALINE EARTH METAL XANTHATE IN A POLAR APROTIC SOLVENT | HOECHST A.G. (DE) | 1984-02-14 | — | — | US | disclosed |
| US-4017489-A | Process of preparing unsymmetrical disulfides | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260145977-A1 | SYSTEM AND METHOD OF USING NANOBUBBLES IN A DEWATERING PROCESS FOR A LIQUID-SOLID STREAM | FLNB, FLNA, DSP | ALDH1A1 4013/4885TSHR 2566/4885MAPT 628/4885 |
| US-12614711-B2 | Passivating agents for electrochemical cells | CACNA2D1, CACNA2D3, CACNA1D | ALDH1A1 286/4885TSHR 1923/4885MAPT 3848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.